Ketamine Recruiting Phase 4 Trials for Major Depressive Disorder (MDD) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02644629Intra-nasal vs. Intra-venous Ketamine Administration
NCT01260649N-methyl-D-aspartate Antagonist (Ketamine) Augmentation of Electroconvulsive Treatment for Severe Major Depression